Physician

Andrew Elson, MD

According to 2025 Medicare claims, Andrew Elson, MD (NPI: 1649596107) practices radiation oncology in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70403-1434.

Elson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 392 traditional Medicare patients, billed 11,327 HCPCS/CPT codes, and received $870,028 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 294 prescription claims across 122 beneficiaries totaling $22,338 in drug costs, led by Nystatin (Nystatin). Open Payments data shows 12 records totaling $441. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $138,723 to $870,028. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,096 and ending at $22,338. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$511K$1.0M2015 Medicare payment: $138,723 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $635,840 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $665,405 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $734,040 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $849,385 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $792,849 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $720,750 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,022,315 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $878,157 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $870,028 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015901,794$138,723
20163786,839$635,840
20173437,499$665,405
20183789,825$734,040
201939510,184$849,385
202037510,214$792,849
20213738,671$720,750
202240416,003$1,022,315
202341115,314$878,157
202439211,327$870,028

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$25K2015 Drug cost: $1,096 (USD; Tot_Drug_Cst)2016 Drug cost: $10,359 (USD; Tot_Drug_Cst)2017 Drug cost: $12,240 (USD; Tot_Drug_Cst)2018 Drug cost: $23,706 (USD; Tot_Drug_Cst)2019 Drug cost: $24,817 (USD; Tot_Drug_Cst)2020 Drug cost: $10,821 (USD; Tot_Drug_Cst)2021 Drug cost: $15,728 (USD; Tot_Drug_Cst)2022 Drug cost: $15,571 (USD; Tot_Drug_Cst)2023 Drug cost: $7,194 (USD; Tot_Drug_Cst)2024 Drug cost: $22,338 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R14$1,096
201665280$10,359
2017110370$12,240
2018147567$23,706
2019144529$24,817
2020124356$10,821
2021124373$15,728
2022122375$15,571
202394224$7,194
2024122294$22,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78815Nuclear medicine study from skull base to mid-thigh with ct scan137152$1,038
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session81570$244
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries125142$95
77014Ct guidance for insertion of radiation therapy fields115708$85
77336Continuing radiation therapy consultation per week82183$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NystatinNystatin28419$555
Lidocaine Hcl ViscousLidocaine Hcl1790$369
Ondansetron HclOndansetron Hcl18470$299
Oxycodone HclOxycodone Hcl16383$208
Promethazine HclPromethazine Hcl13380$188

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$441Novocure Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Elson, MD?

Tedicare shows public-source Medicare data for Andrew Elson, MD (NPI 1649596107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Elson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Elson, MD?

Andrew Elson, MD is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Andrew Elson, MD have Open Payments data?

Andrew Elson, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.